Consolidated Statements of Cash Flows (unaudited) (USD $) In Thousands	9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Cash flows from operating activities:
Net earnings	$ 3,194	$ 3,924
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	2,504	2,623
Provision for loan losses	3,150	4,150
Provision for deferred tax expense	(189)	(838)
Amortization of premiums on securities, net	679	909
Amortization of other investments	10	0
Stock compensation expense	14	5
Restricted stock expense	52	23
Net gain on sale of investment securities	(99)	0
Net loss on sale of other real estate	66	146
Net loss on sale of premises and equipment	15	62
Change in accrued interest receivable	(447)	(181)
Change in accrued interest payable	(275)	(300)
Change in other assets and other liabilities, net	2,050	2,322
Write down of other real estate owned	434	241
Net cash provided by operating activities	11,158	13,086
Cash flows from investing activities net of effect of purchase acquisition in 2011:
Net decrease in time deposits in other banks	5,164	21,062
Proceeds from maturities and calls of securities available-for-sale	58,990	26,278
Proceeds from maturities and calls of securities held-to-maturity	900	1,456
Proceeds from sale of securities available-for-sale	3,895	0
Purchases of securities available-for-sale	(118,517)	(26,107)
Purchases of securities held-to-maturity	(43,403)	0
Purchases of other investments	(5)	(173)
Net change in loans	(46,652)	(18,067)
Purchases of premises and equipment	(2,947)	(689)
Proceeds from sale of premises and equipment	6	3
Net cash associated with Jefferson Bank acquisition	93,800	0
Proceeds from sale of other real estate	613	766
Purchase of other real estate	0	(450)
Net cash (used in) provided by investing activities	(48,156)	4,079
Cash flows from financing activities net of effect of purchase acquisition in 2011:
Change in deposits	22,465	6,320
Change in securities sold under agreements to repurchase	11,252	6,032
Change in federal funds purchased	0	(1,700)
Issuance of Series B preferred stock	32,000	0
Redemption of Series A preferred stock	(20,000)	0
Issuance of common stock and treasury stock, net of offering expenses	0	4,769
Payment of dividends on preferred stock	(778)	(750)
Payment of dividends on common stock	(2,046)	(1,825)
Proceeds from exercise of stock options	0	17
Net cash provided by financing activities	42,893	12,863
Net increase in cash and cash equivalents	5,895	30,028
Cash and cash equivalents, beginning of period	91,907	23,351
Cash and cash equivalents, end of period	97,802	53,379
Supplemental information- Noncash items
Accretion of warrants	592	148
Transfer of loans to other real estate	7,185	1,183
Net change in loan to ESOP	$ (87)	$ (84)